header logo image


Page 727«..1020..726727728729..740750..»

High Genetic Risk Score Associated With Organ Damage, Renal Dysfunction, and All-Cause Mortality in SLE – Rheumatology Advisor

January 15th, 2020 1:42 am

High genetic risk score (GRS) may predict organ damage, end-stage renal disease, and all-cause mortality in patients with systemic lupus erythematosus (SLE), according to study results published in Annals of Rheumatic Disease.1

Investigators genotyped data of a discovery cohort and a replication cohort that included patients with SLE and healthy controls. Patients with SLE (n=1001) were enrolled in the discovery cohort from various clinics in Sweden; healthy controls (n=2802) were enrolled from blood donor centers in the same areas. The replication cohort included 5524 patients with SLE and 9859 healthy controls of European descent, initially enrolled for a study published in 2017.2 Genotyping data were collected from both cohorts using a 200K Immunochip single nucleotide polymorphism array. Cumulative GRSs were assigned to each study participant based on 57 SNPs with known associations to SLE. Risk allele counts of the 57 SNPs were calculated for each participant by summing the total number of risk alleles. Ordinal and logistic regression were used to assess GRS differences between patients and healthy controls.

Results indicated that SLE was more prevalent in the high GRS quartile compared with the low GRS quartile in both the discovery (odds ratio [OR], 12.32; 95% CI, 9.53-15.71; P =7.910-86) and replication (OR, 7.48; 95% CI, 6.73-8.32; P =2.210-304) cohorts. In the discovery cohort, compared with patients in the low GRS quartile, those in the high GRS quartile had a 6-year earlier mean disease onset (33 vs 39 years; P =4.310-5), higher prevalence of damage accrual (OR, 1.47; 95% CI, 1.06-2.04; P =2.010-2), and higher prevalence of any renal disorder (OR, 2.22; 95% CI, 1.50-3.27; P =5.910-5), end-stage renal disease (OR, 5.58; 95% CI, 1.50-20.79; P =1.010-2), and proliferative nephritis (OR, 2.42; 95% CI, 1.30-4.49; P =5.110-3).

Patients in the high GRS quartile vs the low GRS quartile of the discovery cohort were also more likely to have a positive antiphospholipid antibodies test (OR, 1.84; 95% CI, 1.16-2.9; P =9.410-3), with more than doubled odds of being triple positive (OR, 2.27; 95% CI, 1.02-5.09; P =4.610-2). In survival analyses conducted in the discovery cohort, compared with the low GRS quartile, the high GRS quartile displayed earlier onset of first organ damage (43 vs 51 years), first cardiovascular event (45 vs 51 years), nephritis (31 vs 39 years), and end-stage renal disease (43 vs 64 years). Decreased overall survival was also observed in the high-to-low quartile comparisons (hazard ratio, 1.83; 95% CI, 1.02-3.30; P =4.310-2).

These data support the prognostic capacity of GRS for SLE outcomes. The highest GRS quartile was strongly associated with poorer outcomes, including organ damage, cardiovascular events, renal dysfunction, and all-cause mortality. Our results indicate that genetic profiling may be useful for predicting outcomes in patients with SLE, the investigators wrote.

References

1. Reid S, Alexsson A, Frodlund M, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus [published online December 11, 2019]. Ann Rheum Dis. doi:10.1136/annrheumdis-2019-216227

2. Langefeld CD, Ainsworth HC, Vyse TJ. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017;8:16021.

Excerpt from:
High Genetic Risk Score Associated With Organ Damage, Renal Dysfunction, and All-Cause Mortality in SLE - Rheumatology Advisor

Read More...

Filling In The Gaps Of Asia’s Genetic Map – Asian Scientist Magazine

January 15th, 2020 1:42 am

AsianScientist (Jan. 14, 2019) An international team of scientists has sequenced the genomes of almost 2,000 Asians to find clues about Asian ancestry, health and disease. Their findings are published in Nature.

Despite forming over 40 per cent of the worlds population, Asian people have previously accounted for only six per cent of the worlds recorded genome sequences.

To raise the representation of Asian genomes in biomedical studies, Nanyang Technological University, Singaporetogether with Macrogen, South Korea; Genentech, US; and MedGenome, India/USlaunched the GenomeAsia 100K consortium in 2016. The consortium aims to understand the genome diversity of Asian ethnicities by sequencing 100,000 genomes of people living in Asia.

GenomeAsia 100K is a significant and far-reaching project that will affect the well-being and health of Asians worldwide, said NTU Professor Stephan C. Schuster, the consortiums scientific chairman and a co-leader of the study.

In the present study, the researchers analyzed the genomes of 1,739 people, which represents the widest coverage of genetic diversity in Asia to date. Genomic DNA was extracted from blood and saliva samples, then sequenced in the laboratories of the four consortium members. The digital sequencing data were subsequently sent to Singapore for processing and storage.

Zooming in on the frequencies of known genetic variants related to adverse drug response, the team reported that Warfarin, a common anticoagulant drug prescribed to treat cardiovascular diseases, has a higher frequency of appearance in individuals with North Asian ancestry, such as Japanese, Korean, Mongolian or Chinese.

Using this data, scientists can now screen populations to identify groups that are more likely to have a negative predisposition to a specific drug. Knowing a persons population group and their predisposition to drugs is extremely important if personalized medicine is to work, Schuster emphasized.

In addition, the researchers discovered that Asia has at least ten ancestral lineages, whereas northern Europe has a single ancestral lineage. Moving forward, the GenomeAsia 100K consortium will continue to collect and analyze up to 100,000 genomes from all of Asias geographic regions to fill in the gaps of the worlds genetic map and to account for Asias unexpected genetic diversity.The article can be found at: GenomeAsia100K Consortium (2019) The GenomeAsia 100K Project Enables Genetic Discoveries Across Asia.

Source: Nanyang Technological University; Photo: Shutterstock.Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

More here:
Filling In The Gaps Of Asia's Genetic Map - Asian Scientist Magazine

Read More...

Suicide rates sharply higher than average in teens, young adults with diabetes – Reuters

January 15th, 2020 1:41 am

Young people with diabetes are at greater risk than peers without the disease of developing mental health problems or attempting suicide as they transition into adulthood, a Canadian study suggests.

Based on data for more than 1 million young people born in Quebec, researchers found that being diagnosed with diabetes is associated with increased odds of being diagnosed in an emergency room or hospital with a mood disorder like depression. Its also linked to higher odds of being admitted to a hospital for a suicide attempt, according to the report in Diabetes Care.

Between the ages of 15 and 25, adolescents and young adults with diabetes are 325% as likely to attempt suicide as their same-age peers, and 133% as likely to suffer from a mood disorder, said Dr. Marie-Eve Robinson, a pediatric endocrinologist at the Childrens Hospital of Eastern Ontario, in Ottawa, Canada, who led the study.

Past research has explored risks for psychiatric disorders in individuals with and without type-1 diabetes, Robinson and her colleagues write in Diabetes Care, but the risks during the transition from adolescence to adulthood have not been assessed.

In addition to challenges inherent to adolescence, young adults with diabetes who transition to adult care need to adapt to a new adult-care provider and a treatment facility, Robinson told Reuters Health.

Young adults tend to perceive pediatricians as more family-centered and less formal compared to adult-care providers and this can sometimes make the transition difficult, she explained.

Type-1 diabetes, formerly known as juvenile diabetes, occurs when the pancreas makes little or no insulin; the disease typically emerges in childhood or adolescence. Type-2 diabetes, the more common form of the illness, is associated with aging and overweight and occurs when the body becomes less responsive to insulin.

Young people with type-1 diabetes must also take full responsibility for managing their diabetes, Robinson said, which includes injecting insulin multiple times a day, monitoring their glucose and paying close attention to diet and physical activity.

This can be overwhelming, especially when their previous caregivers were providing significant support during childhood and adolescence.

To assess the mental health toll of these burdens, the researchers used Quebec registries to identify people born between April 1982 and December 1998 without any mental illness diagnosed before age 15. The final analysis included 3,544 adolescents diagnosed with diabetes between ages 1 and 15, and nearly 1.4 million young people without diabetes.

The study team followed the youths from age 15 to 25 and found that in addition to increased risks for a mood disorder diagnosis or a suicide attempt, youth with diabetes were almost twice as likely to visit a psychiatrist, compared to peers without diabetes.

With diabetes, young people also had a 29% higher risk of being diagnosed with any psychiatric disorder. However, there were no differences between the groups in schizophrenia diagnoses.

Even without a diagnosis of diabetes, there is a lot of anxiety and depression nowadays in the adolescent population, said Dr. Anastassios G. Pittas, co-director of the Diabetes and Lipid Center, at Tufts Medical Center in Boston.

To be diagnosed, on top of that, with a chronic, incurable medical condition that affects essentially every minute of ones life has a huge impact, Pittas, who was not involved in the current study, told Reuters Health in a phone interview.

However, depending on the age of the child, a major medical diagnosis need not always have a negative impact, he added.

For Pittas, one major limitation of the study was the large range in ages at which diabetes was diagnosed, and he would have liked to see if there were differences in mental health risk on that basis.

Children diagnosed with diabetes at age 1 or 2 do not know life without diabetes, said Pittas, adding that kids diagnosed before ages 7 or 8 tend to do better than those diagnosed in the middle of adolescence.

Even so, the study authors note in their report, endocrinologists who treat young adults rarely receive a patients psychosocial summary as part of their referral documents from their pediatric colleagues.

As children with diabetes will inevitably transfer to adult care, pediatric and adult healthcare providers should be aware of the increased risk of developing mental health problems, Robinson said.

SOURCE: bit.ly/2uvRfH0 Diabetes Care, online December 16, 2019.

Originally posted here:
Suicide rates sharply higher than average in teens, young adults with diabetes - Reuters

Read More...

Tulsa diabetes advocate: ‘People are dying because they can’t afford their insulin.’ – kjrh.com

January 15th, 2020 1:41 am

TULSA, Okla. A medication keeping people alive costs too much to do just that.

The price for insulin is skyrocketing, which forces some diabetics to choose between their health or paying other bills.

One woman is working to change that. Megan Quickle is a diabetes advocate and lives with type 1 diabetes.

"People are dying because they can't afford their insulin. People are rationing their insulin, they're using less than they should be and it's taking a tremendous toll on their diabetes. This is not ok."

No one seems to know why insulin is so expensive, but the American Diabetes Association blames the complicated supply chain.

A lot of hands are involved, and many factors impact how much patients pay, including the amount and type of insulin, the delivery system used, and whether insurance is involved.

It's kind of a circle, loop that people are just pointing the finger at different people."

The A.D.A. calculates, more than 30 million Americans live with diabetes.

Quickle says lawmakers are working on a bill, but that it will only help a few dealing with this disease. She hopes state lawmakers will draft and pass an insulin affordability bill for all soon.

"If we are all using our same voice and advocating our government, saying, 'This is unacceptable,' maybe they'll listen to us."

There are ways to get cheaper insulin through different company programs like the Lily Diabetes Solution Center or Novo Nordisk . Patients are also encouraged to ask their pharmacies of any a rebate program.

Stay in touch with us anytime, anywhere.

Download our free app for Apple and Android and Kindle devices.

Sign up for newsletters emailed to your inbox. Select from these options: Breaking News, Severe Weather, School Closings, Daily Headlines and Daily Forecasts.

Follow us on Twitter

Like us on Facebook

Link:
Tulsa diabetes advocate: 'People are dying because they can't afford their insulin.' - kjrh.com

Read More...

Is It Safe to Eat Mango If You Have Diabetes? – Healthline

January 15th, 2020 1:41 am

Often referred to as the king of fruits, mango (Mangifera indica) is one of the most beloved tropical fruits in the world. Its prized for its bright yellow flesh and unique, sweet flavor (1).

This stone fruit, or drupe, has been primarily cultivated in tropical regions of Asia, Africa, and Central America, but its now grown across the globe (1, 2).

Given that mangoes contain natural sugar, many people wonder whether theyre appropriate for people with diabetes.

This article explains whether people with diabetes can safely include mango in their diets.

Mangoes are loaded with a variety of essential vitamins and minerals, making them a nutritious addition to almost any diet including those focused on improving blood sugar control (3).

One cup (165 grams) of sliced mango offers the following nutrients (4):

This fruit also boasts small quantities of several other important minerals, including magnesium, calcium, phosphorus, iron, and zinc (4).

Mango is loaded with vitamins, minerals, and fiber key nutrients that can enhance the nutritional quality of almost any diet.

Over 90% of the calories in mango come from sugar, which is why it may contribute to increased blood sugar in people with diabetes.

Yet, this fruit also contains fiber and various antioxidants, both of which play a role in minimizing its overall blood sugar impact (2).

While the fiber slows the rate at which your body absorbs the sugar into your blood stream, its antioxidant content helps reduce any stress response associated with rising blood sugar levels (5, 6).

This makes it easier for your body to manage the influx of carbs and stabilize blood sugar levels.

The glycemic index (GI) is a tool used to rank foods according to their effects on blood sugar. On its 0100 scale, 0 represents no effect and 100 represents the anticipated impact of ingesting pure sugar (7).

Any food that ranks under 55 is considered low on this scale and may be a better choice for people with diabetes.

The GI of mango is 51, which technically classifies it as a low GI food (7).

Still, you should keep in mind that peoples physiological responses to food vary. Thus, while mango can certainly be considered a healthy carb choice, its important to evaluate how you respond to it personally to determine how much you should include in your diet (8, 9).

Mango contains natural sugar, which can contribute to increased blood sugar levels. However, its supply of fiber and antioxidants may help minimize its overall blood sugar impact.

If you have diabetes and want to include mango in your diet, you can use several strategies to reduce the likelihood that it will increase your blood sugar levels.

The best way to minimize this fruits blood sugar effects is to avoid eating too much at one time (10).

Carbs from any food, including mango, may increase your blood sugar levels but that doesnt mean that you should exclude it from your diet.

A single serving of carbs from any food is considered around 15 grams. As 1/2 cup (82.5 grams) of sliced mango provides about 12.5 grams of carbs, this portion is just under one serving of carbs (4, 10).

If you have diabetes, start with 1/2 cup (82.5 grams) to see how your blood sugar responds. From there, you can adjust your portion sizes and frequency until you find the amount that works best for you.

Much like fiber, protein can help minimize blood sugar spikes when eaten alongside high carb foods like mango (11).

Mango naturally contains fiber but isnt particularly high in protein.

Therefore, adding a protein source may result in a lower rise in blood sugar than if you were to eat the fruit by itself (11).

For a more balanced meal or snack, try pairing your mango with a boiled egg, piece of cheese, or handful of nuts.

You can minimize mangos impact on your blood sugar by moderating your intake and pairing this fruit with a source of protein.

Most of the calories in mango come from sugar, giving this fruit the potential to raise blood sugar levels a particular concern for people with diabetes.

That said, mango can still be a healthy food choice for people trying to improve blood sugar control.

Thats because it has a low GI and contains fiber and antioxidants that may help minimize blood sugar spikes.

Practicing moderation, monitoring portion sizes, and pairing this tropical fruit with protein-rich foods are simple techniques to improve your blood sugar response if you plan to include mango in your diet.

See more here:
Is It Safe to Eat Mango If You Have Diabetes? - Healthline

Read More...

First year of the Montreal Heart Institute’s Diabetes Prevention Clinic supported by Sun Life Financial – Yahoo Finance

January 15th, 2020 1:41 am

Patients on the road to recovery from type 2 diabetes

MONTREAL , Jan. 13, 2020 /CNW/ - What if you were told you could reverse the course of type 2 diabetes through exercise and a healthy diet? That was the challenge this past year for patients at the Montreal Heart Institute's Diabetes Prevention Clinic supported by Sun Life Financial. The health team is thrilled with the progress achieved by its 180 participants during the clinic's first year.

"These are impressive results after just one year!I congratulate the patients who undertook this challenge and I thank the clinic's health care professionals who've helped guide them on their road to recovery," said Jacques Goulet , President of Sun Life Canada. "With so many Canadians affected by diabetes, Sun Life is committed to fighting the disease and its potentially serious complications. This initiative aligns with our purpose, which is to help our Clients achieve lifetime financial security and live healthier lives. "

"Lifestyle is better than medication for treating diabetes, and doesn't involve the side effects frequently associated with medication. The clinic delivers the best tools to patients, so they can minimize complications related to their disease," said Dr. Martin Juneau , Director of Prevention at the Montreal Heart Institute and Diabetes Prevention Clinic supervisor.

A multidisciplinary team of health practitioners meets periodically with participants and gives them the tools they need to make healthy lifestyle changes and improve their health. This multidisciplinary program is offered at the Montreal Heart Institute's EPIC Center, thanks to a donation of $450,000 from Sun Life.

A tailored program to meet growing demandThe Diabetes Prevention Clinic's mission is to turn the tide on diabetes through early detection and healthy lifestyle strategies. This program meets a growing demand for preventive services for patients with diabetes and prediabetes, chronic conditions currently affecting 1 in 3 Canadians. Cardiovascular disease is the most common complication and leading cause of death in patients with type 2 diabetes1. Fortunately, many studies show that type 2 diabetics who make lifestyle changes, including a high-quality diet, regular moderate-to-vigorous physical activity, no tobacco use and moderate alcohol consumption, reduce their risk of premature death from cardiovascular disease.

Diabetes is the 5th-leading cause of premature death in the world. Hyperglycemia from the onset of diabetes has multiple adverse effects on cardiovascular risk factors, including atherosclerosis, hypertension and dyslipidemia. These issues, together with the damage hyperglycemia causes to small blood vessels, mean type 2 diabetes increases the incidence of coronary heart disease by 2 to 4 times2.

Sun Life in the community At Sun Life, we are committed to building sustainable, healthier communities for life and we're proud to hold the Caring Company designation from Imagine Canada. Community wellness is an important part of our sustainability commitment and we believe that by actively supporting the communities in which we live and work, we can help build a positive environment for our Clients, Employees, advisors and shareholders. Our philanthropic support focuses on two key areas: health, with an emphasis on diabetes awareness, prevention, care and research initiatives through our Team Up Against DiabetesTM platform; and arts and culture, through our award-winning Making the Arts More AccessibleTM program. Since 2012, Sun Life has committed $31 million globally to support diabetes awareness, prevention, care and research initiatives. In Quebec our sponsorship and donation initiatives also focus on home economics and financial education.

We also partner with sports properties in key markets to further our commitment to healthy and active living. Our Employees and advisors take great pride in volunteering over 29,000 hours each year and contribute to making life brighter for individuals and families across Canada .

About the Montreal Heart InstituteFounded in 1954, the Montreal Heart Institute constantly aims for the highest standards of excellence in the cardiovascular field through its leadership in clinical and basic research, ultra-specialized care, professional training and prevention. It houses the largest cardiovascular research center in Canada , the largest cardiovascular prevention center in the country, and the largest cardiovascular genetics center in the country. The Institute is affiliated with the University of Montreal and has more than 2,000 employees, including 245 doctors and more than 85 researchers.

Story continues

About the Montreal Heart Institute FoundationFounded in 1977, the Montreal Heart Institute Foundation raises and administers funds to support the Institute's priority and innovative projects and fight cardiovascular diseases, the world's number one cause of mortality. Its philanthropic events and the contributions of its donors have enabled this leading cardiovascular health care organization to become the largest cardiac research centre in the country. Since its creation, the Foundation has raised more than $283 million in donations. Its 27,514 donors helped make important discoveries and support specialists, professionals and researchers of the Institute to provide care at the cutting edge of technology to tens of thousands of patients in Quebec .

About the EPIC CenterThe MHI's EPIC Center is the largest centre for cardiovascular disease prevention in Canada , with more than 5500 registered members. The Center has a bit more than 80 employees and is part of the Prevention Branch of the Montreal Heart Institute. The centre is for healthy people who wish to keep it that way (primary prevention) as well as for patients who had a cardiac accident (readaptation and secondary prevention). The staff includes physicians, cardiologists, internists, emergency physicians, a physiologist, visiting professors, nurses, nutritionists, kinesiologists and rescuers.

Montreal Heart Institute Foundation Isabelle Pelletier 514 238-4178Ipelletier.pr@gmail.com

Sun LifeMylne Blanger514-904-9739mylene.belanger@sunlife.com

One year after the opening of the Montreal Heart Institutes Diabetes Prevention Clinic supported by Sun Life Financial, the health team is thrilled with the progress achieved by its participants. (CNW Group/Sun Life Financial Inc.)

Sun Life Financial Inc. (CNW Group/Sun Life Financial Inc.)

Montreal Heart Institute Foundation (CNW Group/Sun Life Financial Inc.)

SOURCE Sun Life Financial Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2020/13/c1437.html

Here is the original post:
First year of the Montreal Heart Institute's Diabetes Prevention Clinic supported by Sun Life Financial - Yahoo Finance

Read More...

Differences in Diabetes Care With and Without Certification as a Medical Home – Annals of Family Medicine

January 15th, 2020 1:41 am

PURPOSE The purpose of this study was to assess whether primary care practices certified as medical homes differ in having the practice systems required for that designation and in attaining favorable outcomes for their patients with diabetes, and whether those systems are associated with better diabetes outcomes.

METHODS We undertook a cross-sectional observational study, Understanding Infrastructure Transformation Effects on Diabetes (UNITED), of 586 Minnesota adult primary care practices, comparing those that were certified vs uncertified as medical homes in 2017, with analyses supplemented by previously published studies of these practices. We collected survey information about the presence of medical home practice systems for diabetes care and obtained 6 standardized measures of diabetes care collected yearly from all Minnesota practices.

RESULTS Of 416 practices completing questionnaires (71% of all practices, 92% of participating practices), 394 had data on diabetes care measures. Uncertified practices (39%) were more likely than certified practices to be rural, but their patient populations were similar. Certified practices had more medical home practice systems (79.2% vs 74.9%, P =.01) and were more likely to meet a composite measure of optimal diabetes care (46.8% vs 43.2%, P <.001). A 1-SD increase in presence of practice systems was associated with a 1.4% higher probability of meeting that measure (P <.001).

CONCLUSIONS Practices certified as medical homes have more practice systems and higher performance on diabetes care than uncertified practices, but there is extensive overlap, and any differences may reflect self-selection for certification.

In the last 10 years, the concept of a medical home for patients, a patient-centered medical home (PCMH), has resurfaced from its origins in pediatrics in 1967.1,2 The idea has received enormous interest in the United States as a potential vehicle for transforming the quality, experience, and costs of medical care. It has even led to creation of a large collaborative, the Patient-Centered Primary Care Collaborative, having more than 1,000 participating organizations,3,4 to promote its spread. There have been many demonstration projects and studies, and there are a variety of national and state processes to recognize or certify practices as PCMHs; however, the definitions and criteria for what constitutes a PCMH vary widely, and most studies lack comparison groups and suffer from volunteer bias.5 There are thus still many unanswered questions, including the following6,7: how do practice systems and outcomes in a PCMH-recognized practice differ from those in others without that designation? Is there a continuum of characteristics and performance among practices that are or are not PCMH recognized, or is there a clear distinction between these groups? And are these practice systems associated with diabetes care quality and outcomes?

The most widely used recognition for what constitutes a PCMH is the process established by the National Committee for Quality Assurance (NCQA).811 Minnesota was one of the first states to implement its own voluntary certification process for primary care practices in 2010, based on demonstration that a practice met 5 standards (criteria) after thorough review12: (1) continuous access and communications with patients and family; (2) an electronically searchable registry to identify care gaps and manage services; (3) care coordination for patient- and family-centered care; (4) care plans that involve patients with chronic or complex conditions; and (5) continuous improvement in patient satisfaction, outcomes, and cost-effectiveness.

These standards must be thoroughly described in an application and demonstrated to be in routine use during required site visits, both initially and at the 3-year recertification point. They are very similar to features the Agency for Healthcare Research and Quality has identified as the key functional attributes of a PCMH: comprehensive care, patient-centered care, coordinated care, accessible services, and quality and safety.13 As an incentive to apply for certification, Minnesota also developed a supplemental payment to certified practices for their Medicaid patients that depended on the complexity of their medical conditions. By late 2017, 61% of the 586 primary care practices in the state and border communities had been certified as a health care home (HCH), Minnesotas term for the PCMH.

The certification standards above require practice processes and systems that can be measured and reviewed triennially. Because all practices in Minnesota are also required to submit standardized data for public reporting on a variety of quality, satisfaction, and cost measures, these data provided us with an opportunity to test whether those practices that were adopters of HCH certification differed in systems and outcomes from uncertified practices. By exploring the differences between these 2 cohorts for adults with diabetes, we hoped to obtain answers to the 3 questions above.

We undertook a cross-sectional observational study, Understanding Infrastructure Transformation Effects on Diabetes (UNITED), of 586 primary care practices, 95% of them contained within 101 medical groups of varying size and type, that participated in Minnesotas 2017 public reporting on quality of care for adult patients with diabetes. Of these, 355 (61%) were certified as HCHs as of July 2017. Practices that were part of multisite medical groups were recruited through their medical directors.

Recruitment involved first sending a letter by Federal Express, followed in 1 week by an e-mail to the medical leader describing the study and its requirements and benefits for them. Participation required identification of the leaders at each practice site and encouragement for their completion of a single questionnaire in 2017. The only benefits for participants were provision of comparative information about their care processes and our findings on successful strategies for improving performance measures. This e-mail was followed by a telephone call from 1 of 2 physician authors (L.I.S. or K.A.P.) who are widely known to the states physicians. Follow-up calls, e-mails, or both were used until leaders verbally consented or declined, or we concluded that we would not be able to obtain an answer.

A leader of each participating practice was asked to complete an 81-question questionnaire asking about the presence of various practice systems to support high-quality care for patients with chronic conditions. The questionnaire was first created and tested for reliability by the National Committee for Quality Assurance as a way of assessing the presence of various features of the Chronic Care Model.14 It has been widely used in research and has been demonstrated to be associated with quality of care for patients with diabetes or depression, and with health care use and costs for patients with diabetes.1517

To create summary measures of practice systems in place, each question was scored as 0 (no such system was present) or 1 (a system was present). We limited our analysis to the 32 questions addressing diabetes care in the 5 domains required for certification in Minnesota (Table 1). Both the overall score and scores for each domain were calculated as a percentage of the total possible score, with equal weight for each question.

Practice Systems Questions for HCH Certification That Address Diabetes Care, in 5 Domains

Diabetes performance measures for each practice were obtained from MN Community Measurement (MNCM), the regions nonprofit organization for collecting and publicly reporting standardized performance measures for medical care.18 For diabetes, these measures include the proportions of diabetic patients having hemoglobin A1c control, having blood pressure control, using statins, using prophylactic aspirin, and not smoking, as well as a composite all-or-none measure of the proportion of patients meeting all 5 measures, indicating optimal diabetes care. Practices use direct data submission procedures to provide these patient-level measures for their diabetic population to MNCM as a part of the Minnesota Department of Health Statewide Quality Reporting and Measurement System.

We first computed summary statistics describing the practices and their diabetic patient populations by certification status, as well as their mean prevalence of practice systems and diabetes care measures. To account for differences in patient and practice characteristics, we also conducted multivariate analyses predicting the presence of practice systems (by certification status with practice characteristics as controls) and predicting patterns in optimal diabetes care (by certification status with both practice and patient characteristics as controls). Practice controls included size of the clinics medical group (large hospital-affiliated organization, small/medium-sized organization, single site), whether the practice was a Federally Qualified Health Center (FQHC), and location of the practice (urban, large rural town, small rural town, isolated rural town). Location was defined by practice ZIP code mapped to Rural-Urban Commuting Area codes (http://depts.washington.edu/uwruca). Patient controls included patient age, sex, record of a diagnosis of ischemic vascular disease, record of diagnosed depression, presence of type 1 diabetes, and insurance type (commercial, Medicare, Medicaid, dual Medicare-Medicaid, self-pay/uninsured). In addition, we mapped patient ZIP code to the American Community Survey19 to pick up measures of the income and education, wealth, and racial composition within the patients neighborhood.

The prevalence of practice systems, in total and by domain, was modeled at the practice level using linear regression with practice control variables. The probability of meeting the overall optimal diabetes care measure, and the probability of meeting each of its 5 components individually, was modeled at the patient level using a logit regression with patient and practice control variables. The practice survey data were cross-sectional (from 2017 only). Practice certification status did not control for volunteer bias, so those practices that were already providing better diabetes care may have been more likely to pursue HCH certification. For this reason, we estimated patient- level optimal diabetes care regression values including practice-level random effects to capture unobserved characteristics of the practices.

Of the 586 primary care practices providing care for adults with diabetes in Minnesota we targeted, 451 (77%) agreed to participate in the study. With diligent follow-up, we obtained completed questionnaires from 416 of these practices, for a 92% completion rate among participating practices and a 71% completion rate among the original 586 practices targeted.

Comparison of practices responding to the survey with nonresponding practices demonstrated that the former were more likely to be in large vertically integrated systems (74% vs 63%, P <.001) and to be located in urban settings (66% vs 43%, P <.001). Responding practices were also more likely to be HCH certified (64% vs 53%, P <.001) and to have patients meeting the optimal diabetes care measure (46% vs 43%, P <.001). Our use of multivariate regression analyses, however, should have normalized our results for observable differences between respondents and nonrespondents.

Among the 394 practices with both practice system data and performance measures for diabetes care, 258 (66%) were certified as HCHs whereas 136 (34%) were still uncertified. Characteristics of these practices by certification status are shown in Table 2. Certified practices were much more likely to be located in urban areas, but were no more likely to be independent or Federally Qualified Health Centers. Patient populations differed slightly by practice certification status, with small differences being statistically significant because of the large sample sizes. Certified practices did, however, have a larger share of patients covered by Medicaid and a smaller share covered by Medicare.

Characteristics of Participating Practices and Their Diabetic Patients, by HCH Certification Status and Overall

Table 3 shows summary statistics describing average HCH practice systems scores and diabetes care measures by certification status. These unadjusted results indicate that the HCH-uncertified practices had fewer practice systems in place, at least for care coordination and care plan development. The standard deviations for the practice systems scores were much larger than any differences between groups, however, indicating extensive overlap between the certification groups. Uncertified practices also had lower a level of the composite measure of optimal diabetes care, as well as lower levels of statin use and nonsmoking status.

Comparison of HCH Practice Systems Scores and Diabetes Care Measures

Table 4 allows more specific comparisons of the above differences after adjusting for differences in practice characteristics (medical group size, location, and Federally Qualified Health Center status) and, for care measures, differences in patient characteristics, in a multivariate analysis. This analysis confirmed the differences in overall practice systems, care coordination, and care plans, but access also now differed significantly by certification status; scores were a significant 4.5% to 9.5% higher for certified practices vs uncertified practices. Adjusted differences in care measures now were significantly higher for the certified group for all measures except for hypertension control, although the absolute differences were smaller (an absolute 0.1% to 5.1%) than those for systems scores.

Adjusted Differences in Practice System Scores and Diabetes Care Measures

Finally, we estimated the impact of an increase in practice systems score on the composite diabetes outcome measure, using patient-level logit regression analysis controlling for patient and practice characteristics (available from the corresponding author). As shown in Table 5, a 1-SD increase was significantly (P <.001) associated with a 1.4% increase in the probability of meeting the composite measure of optimal diabetes care, driven primarily by increases in the hypertension control and hemoglobin A1c control components of that composite.

Adjusted Association of a 1-SD Increase in Overall Practice Systems Score With Diabetes Care Measures

Our findings document that in a state with rigorous PCMH/HCH certification requirements passed by a majority of primary care practices, there were some differences between those that have been certified and those that have not 7 years after certification began. HCH-certified practices were much more likely to be in metropolitan areas and to have a higher proportion of patients covered by Medicaid, but a lower proportion covered by Medicare. Other differences in practice patient characteristics by age, sex, and prevalence of ischemic vascular disease or depression are small.

More importantly, when controlling for these differences, certified practices tended to have both more HCH-related practice systems and higher performance on some measures of the quality of diabetes care. The differences between group averages were not large, however, and there was considerable overlap between certified and uncertified practices with no clear boundary distinction between them as groups. Nevertheless, our finding that a higher practice systems score is associated with better diabetes performance measures suggests that practices wishing to improve their care and outcomes for patients with diabetes should consider how to best improve their practice systems, regardless of whether they are certified as medical homes. In another article, we describe additional analyses that identify those specific practice systems significantly associated with better results, both for all practices and for practice subtypes.20

Wiley et al21 have been studying the presence of what they call care management processes (similar to what we are calling practice systems) for chronic ill ness care in practices nationally and have reported that between 2006 and 2013, there were relatively large increases over time in the overall use of these processes for all sizes of practices. Similarly, Taliani et al22 conducted a qualitative study of care management in 25 practices with PCMH recognition. Interviews with personnel in the practices having the greatest improvement in diabetes performance measures found that they described more patient-centered care manager duties, better use of the electronic medical record for messaging and patient tracking, and stronger integration of the care manager into the care team, all systems that we measured in this study.

Although our study and the literature suggest that practice systems are associated with better performance, a key question is whether differences between certified and uncertified practices in these attributes are due to the certification process or whether they reflect self-selection as practices with more systems and better outcomes choose to become certified. Our cross-sectional study conducted at a point 7 years after certification began cannot answer that question, but other clues may help.

First, in a study of Minnesota HCH practices in 2010, we compared similar diabetes performance measures for the first 120 adult practices to be certified with the much larger sample of 518 practices that were uncertified then.12 At that time, the difference in optimal diabetes care composite scores between certified and uncertified practices was 8.0% vs the 3.5% difference in 2017. More importantly, the difference in these scores 2 years before certification was even larger for those that would become certified than for those that would not, so improvement over the period of attaining certification was actually greater for practices not working on certification.

Second, Shippee et al23 compared patient-level measures of optimal diabetes care for patients served by Minnesota HCH-certified practices with those served by uncertified practices in 2013. At that time, when there was a more equal split between certified and uncertified practices, the difference was 4.0%, similar to the 3.5% we found in 2017,12 suggesting that after certification, further improvement in diabetes scores is not greater for those that have achieved certification. This finding is also consistent with some additional testing using our data set (available from the corresponding author) showing little difference in performance between clinics achieving certification in the first year it was available (July 2010-June 2011) and clinics achieving certification more recently, indicating continued improvement is minimal once certification is achieved.

Third, as PCMH transformation was first gathering steam, the National Demonstration Project conducted a randomized trial among 36 clinics nationally that were highly interested in transformation. Results indicated that outcome measures were no better among clinics receiving extensive external help with that transformation than among those left to work on it on their own.24

Finally, Wang et al25 studied 150 small independent practices, comparing performance on 7 clinical quality measures in 2009 and 2011 between practices that had achieved PCMH recognition from NCQA and those that had not. They found significantly higher performance for PCMH practices at both time points, but the groups had improved at the same rate.

Taken together, these data suggest that practices that chose to be certified may have done so in part because they already had more systems and were performing better on outcome measures. If so, it would help to explain some of the confusing literature on whether medical home clinics provide better care. Instead, at least early adopters of innovations such as the medical home were already better. It also suggests that practices might be better off focusing limited resources on changes they believe will improve care and efficiency rather than on the work required for that designation. Once we have completed a second survey of our study practices and can measure changes over time, we may be able to address that hypothesis more directly.

Despite the unusually large sample of primary care practices in this study and the standardized measures of systems and outcomes, our analysis is limited by the cross-sectional nature of our data as well as the focus on a single state and a single chronic disease (diabetes). The practice systems survey is also limited by reliance on completion by a single participant with no objective verification of the presence of the systems being reported. In early tests of a very similar questionnaire, however, we demonstrated that such respondents did a good job of reporting, tending if anything to underreport practice systems more than overreport them.14

In conclusion, we have shown some differences in characteristics and practice systems, and in performance measures of diabetes care between practices that are certified as medical homes and those that are not. There also appears to be an association between systems and performance, so practices wanting to improve their care and performance measures should improve the number and function of practice systems, regardless of certification status. Most of the differences are small, however, so it is likely that none of these factors represent magic bullets that can be relied on to achieve large gains in performance over short periods of time. Organizational change is as slow as individual behavior change, but those interested in facilitating improvement need guidance on what changes will be most helpful, and that is the central goal of this ongoing project.

Conflicts of interest: authors report none.

To read or post commentaries in response to this article, see it online at http://www.AnnFamMed.org/content/18/1/66.

Funding support: Research reported in this publication was supported by the National Institute of Diabetes, Digestive, and Kidney Diseases of the National Institutes of Health under Award Number R18DK110732.

Disclaimer: The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read more:
Differences in Diabetes Care With and Without Certification as a Medical Home - Annals of Family Medicine

Read More...

3 Top Diabetes Stocks to Watch in January – The Motley Fool

January 15th, 2020 1:41 am

Diabetes is a massive market in the healthcare sector. An estimated 415 million people have diabetes worldwide, and those numbers are growing. It's also an on-going healthcare issue, one that patients have to manage, often for the rest of their lives. As such, there is a lot of recurring revenue. It's not a bad idea to find a strong company focused on this vertical to add to your portfolio.

Over the last decade, one of the biggest stocks in healthcare has been diabetes specialistDexCom (NASDAQ:DXCM), a wireless health company that allows patients and doctors to track glucose levels in real-time. Another potential winner in this space isLivongo Health(NASDAQ:LVGO), an up-and-coming small-cap that sends updates, reminders, and coaching tips to all its clients with diabetes (and other health issues). And biotech companyProvention Bio(NASDAQ:PRVB)is hoping to get approval from the Food and Drug Administration (FDA) for a drug that delays the onset of type 1 diabetes. Read more to see if any of these stocks are buys right now.

Image source: Getty Images

DexCom, a $21 billion large-cap stock, has been dominant in healthcare for a long time. Over the last 10 years, shareholders have been rewarded with a 2,563% return. DexCom achieved that impressive return with a singular focus on diabetes. Traditionally, people with diabetes had to prick their finger to check their blood in order to monitor their insulin level. DexCom introduced a wireless device inserted under their skin. This sensor, called a continuous glucose monitor (CGM), is appreciated by patients because of its ease of use and valued by doctors because of its superior data and better health outcomes.

DexCom recently signed a distribution deal withWalgreens Boots Allianceto sell the CGM device. Patients insert a tiny sensor under the skin using an automatic applicator.DexCom's sensor starts automatically and continuously taking glucose readings in the patient's interstitial fluid. A micro-transmitter sends the data wirelessly to a receiver. Patients can read their own data in any connected smart device. The CGM can also be set to alert the patient if certain glucose levels are reached.

In its most recent quarter, DexCom reported $396 million in revenue for the quarter, 49% higher than the previous year. Net income was $60 million for the quarter. DexCom's main competition in this space is withAbbott Laboratories(NYSE:ABT)that sells a popular CGM device calledFreestyle Libre. Abbott's CEO Miles White predicted in a conference call last year that his company's device would achieve sales of $5 billion a year (which would dwarf DexCom's $1.35 billion). So far, DexCom's fantastic numbers suggest DexCom is still winning in the diabetes space. Even with competition, clearly the market opportunity is vast.

Livongo Health is a fascinating company and a rising star in personalized medicine. While unprofitable, the company has phenomenal revenue growth. It brought in $46 million in sales in its most recent quarter,up 148% year over year. Over 200,000 diabetes patients are on Livongo's messaging platform, up 118% year over year, and the company has 771 enterprise clients.The company is creating additional verticals in prediabetes, hypertension, weight management, and behavioral health. Livongo specializes in helping all patients with chronic conditions, giving them advice, coaching tips, and interpretations of data readouts.

The company has conducted 48 studies measuring return on investment (ROI) and found that 90% of its clients had positive ROI in the first year. Indeed, some corporate clients are so happy with Livongo's offering, the clients are offering to reduce or eliminate the co-pay for hypertension or diabetes drugs for their employees, as long as the employees subscribe to Livongo.

So far, Livongo's stock has been a disappointment, down 30% from the company's initial public offering in July 2019.The company has a $2.5 billion market cap, $400 million in cash, and no debt. Its price-to-sales ratio is 17, about the same as DexCom, while Livongo is growing revenues three times as fast.Gross margins are 74%, suggesting the company can become profitable at any time. Right now though, the company is focused on escalating its top-line growth.Livongo has formed partnerships with MDLIVE and Doctor on Demand to enable virtual access to doctors for all its clients, which will roll out in 2020.The future looks bright for Livongo Health.

Provention Bio is an interesting biotech focused on preventing diseases before they become acute. It's a tiny company right now, with a market cap of $658 million.But the stock has been running wild, up 741% last year. What caused the stock to take off? The company reported amazing results in its phase 2 study for Teplizumab, a drug designed to delay the onset of diabetes in at-risk patients.

In this long-term study, the median patients on placebo developed diabetes in two years. That's in sharp contrast to the group on Provention's drug. Those median patients developed diabetes in four years. In fact, 73% of the people on placebo developed diabetes, compared to 43% of those on Teplizumab. Thus the drug not only delayed the onset of diabetes, on average, but many patients avoided diabetes altogether. The numbers were so good, the FDA decided the company can file its new drug application on the basis of its phase 2 study.

Provention has no profits and no revenues, so like many biotech stocks, it has to be considered speculative. On the other hand, the risk/reward ratio is very intriguing, since the diabetes market is so large.

After all, diabetes is a $45 billion market in the U.S. alone.Worldwide, the diabetes market will surpass $85 billion by 2022. It's a huge market opportunity for all three of these companies. Of the three stocks, DexCom has the largest upside. The stock has quadrupled over the last two years, so patient investors might wait for a better price.

Read more:
3 Top Diabetes Stocks to Watch in January - The Motley Fool

Read More...

Finally, a pill that could fix the root cause of diabetes – ISRAEL21c

January 15th, 2020 1:41 am

Of the 463 million people in the world with diabetes, up to 95 percent have type 2 (T2D). In T2D, peripheral tissues mostly muscles are resistant to insulin, a hormone made by the pancreas to stabilize blood-sugar levels and enable the body to use and store sugar.

Medications available today treat the symptoms and complications of T2D but do not solve the core problem of insulin resistance.

Zygosid-50, a drug under development in Israel, could be the first to restore near-normal cellular sensitivity to insulin, without side effects.

Concenter BioPharma in Jerusalem is raising funds for clinical trials approved by the FDA based on evidence from earlier testing in animal models for T2D.

In December, Concenter Biopharma cofounder and CSO Prof. Mottie (Mordechai) Chevion won first place at the 17th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Diseases.

The World Congress attracts the top researchers and clinicians, who understand the problem and the limited solutions available which arent really solutions at all, says Concenter Biopharma cofounder and CEO Dror Chevion, Motties son.

To receive the award out of 80 submitted abstracts and six chosen for presentation is a real vote of confidence in our science and our achievements, Dror Chevion tells ISRAEL21c. The people sitting in that conference will be the ones prescribing our drug to patients.

Concenter BioPharma cofounder and CSO Prof. Mottie Chevion, left, receiving his award from Dr. Zachary Bloomgarden at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Diseases in Los Angeles, December 2019. Photo: courtesy

Mottie Chevion developed the nonsteroidal, anti-inflammatory Zygosid family of drugs in his lab at Hebrew University-Hadassah Medical Center in Jerusalem.

Zygosids work by robustly reducing insulin resistance and normalizing all diabetes-associated parameters to the normal range, says the professor. On the molecular level, Zygosid-50 is a potent anti-inflammatory drug that forces an intra-cellular exchange removal of bad free iron with zinc, depositing the zinc ion within the cells.

In 2015, some of the lab staff and their families successfully tried using Zygosid molecules topically for skin conditions including diabetic foot ulcers and psoriasis. They experienced no negative side effects.

My father felt it was inhumane not to try to bring these drugs from the lab to patients. He asked me to join him and take this initiative forward, says Dror Chevion.

The intellectual property was licensed to the inventors through the university and hospital tech-transfer companies. Silkim Pharma was set up as a holding company for the IP. Concenter Biopharma was founded as a subsidiary in 2019 to further develop and commercialize Zygosid-50 for treating and preventing T2D.

1 in 3 people has diabetes or prediabetes

Concenters US regulatory consultant, Dr. Susan Alpert, arranged meetings with the FDA in 2017 and 2018 to help determine which indication to focus on. The conclusion was to start with T2D and conduct clinical phase 1 and phase 2a trials in Israel while finalizing a pill formulation and completing preclinical toxicity studies.

One in three people in the world is diabetic or prediabetic, says Dror Chevion. The number is expected to reach 700 million by 2045. In the United States, 31 million people suffer from diabetes and 90 million are prediabetic. And the age of people contracting type 2 diabetes is getting younger and younger.

In animal trials, Zygosid-50 restored insulin sensitivity by better than 90%, bringing blood sugar into balance and lowering chronic and systemic inflammation levels. The drug also replenished zinc deficiency.

The FDA responded to Concenters investigational new drug (IND) application with a request for additional preclinical toxicity studies and more information on the drugs manufacturing process.

This is a great achievement for a small company, notes Dror Chevion.

We are working on accommodating those requests and making the final formulation of the drug as a pill. We plan to perform clinical studies here in Israel. Then we will submit another IND application to go to phase 2b, by the end of 2020. We are currently raising funds to do all of that.

Concenter was self-funded until six months ago. The company will launch a $5 million round for its T2D activities during 2020.

Concenter BioPharmas scientific advisory board includes three globally recognized diabetes experts: Dr. Peter Nawroth of Germany, Dr. Ralph DeFronzo from the United States, and Dr. Itamar Raz, chairman of the Israeli Council on Diabetes and the National Diabetes Prevention and Care Plan.

Diabetes is a global epidemic and is expected to grow, says Dror Chevion. The estimated cost of treating diabetes per year is over $850 billion. More than 150 companies are developing diagnostics or applications for diabetes, but there are no drugs to treat the actual problem of insulin resistance without side effects. This is what we are doing.

For more information, click here

More:
Finally, a pill that could fix the root cause of diabetes - ISRAEL21c

Read More...

A Type 2 diabetes diagnosis can overwhelm you. But with the right information, you can go on. – NBC News

January 15th, 2020 1:41 am

My mother had Type 2 diabetes. While she was living with and going through that, I didn't know about the strong connection between Type 2 diabetes and heart disease; I just worked to try to make her comfortable and manage the day to day. Perhaps if I had known that people living with diabetes are twice as likely to develop and die from cardiovascular disease, we could have asked her doctor different questions and been more diligent in helping her manage the risk to the complication that would eventually claim her life.

My mother made her transitionbecause of heart failure resulting from her Type 2 diabetes.

She was a woman who truly cared about people in her community. When I wasn't around, my mother spent time with all kinds of folks she had met especially young people she adored. When she passed, so many individuals she had met wrote me cards. I had no idea that she really spoke to them and brought so much into their lives. She was a simple and hard-working woman. She never made a lot of money, but she had an impact on the lives of those she met.

Get the think newsletter.

I decided that trying to help my mother continue making an impact on people's lives was a way I could honor her. That was why I teamed up with the American Diabetes Association and the American Heart Association to get the message out about the connection between Type 2 diabetes, heart disease and stroke. We are trying to help people like my mother.

For many people, when you hear news that's overwhelming like a diagnosis of diabetes you have one of two reactions: You either feel like your feet are being held to the fire and decide, Let's get moving, let's do something about this; or it's like, Oh my God, it's just all too much for me. The collaboration between the American Heart Association and the American Diabetes Association, called Know Diabetes by Heart, helps those people who are newly diagnosed with Type 2 diabetes (and their loved ones and family members) break down what to do next into bite-size portions, to get a handle on what it all means, so they can manage it and stay in the know.

One important thing we are trying to do is help people have conversations with their doctors about managing their cardiovascular health. I know from experience that it's even hard to know the right questions to begin those conversations. You can start by asking: What changes can I make today? What can I do before my next appointment? What changes can I make to take care of my heart in the long term? How will I know if those changes are having an effect?

Everyone is different so its important to always work closely with your doctor on the treatment thats right for you. Go to KnowDiabetesbyHeart.org for a discussion guide you can print out and take with you, or bring it up on your phone at your appointment.

The site also has stories from people who are dealing with this issue. They are sharing their personal stories to encourage you, and to remind you, that you are not alone. There are even good recipes on the site to help with the dietary changes. Like many people, nutrition was particularly difficult for my mother when dealing with her diabetes. You eat what you like for so many years 65 years, for her and then you get this diagnosis and you think: Now I'm supposed to change. How? Where do I start? This is one way.

The other part of this is that non-Hispanic blacks, Hispanic Americans and Native Americans are at a significantly higher risk to develop Type 2 diabetes, which researchers think is a result of a combination of factors, including genetics, lifestyle factors, environmental factors and socioeconomic conditions.

Beyond that, we all know that, in this country, there is a great disparity in access to and quality of health care, which also plays out when it comes to Type 2 diabetes and its complications.

For instance, a 2017 study by the Centers for Disease Control and Prevention showed that, though the risk of eye disease among Type 2 diabetes patients is well known, African American and Latino Medicaid patients with Type 2 diabetes were significantly less likely to be offered eye exams than white patients. A 2007 study in Family Medicine showed that even if you control for access to health care and socioeconomic status, Latino patients with Type 2 diabetes were less likely than white patients to have foot exams from their doctors, even though the risk of damage to patients' extremities is well known.

That is why it is so important that everyone has access to information, resources and support, and that they know what questions to ask their doctors and how to follow up. Through Know Diabetes by Heart we want to show people living with Type 2 diabetes that theyve been diagnosed with a new purpose. Yes, you have Type 2 diabetes and, yes, you can manage it and live your amazing life.

As told to THINK editor Megan Carpentier, condensed and edited for clarity.

Angela Bassett is an Academy-award nominated actor, a director and an activist. She is currently serving as an ambassador for Know Diabetes by Heart, a joint initiative of the American Heart Association and the American Diabetes Association.

Read the original:
A Type 2 diabetes diagnosis can overwhelm you. But with the right information, you can go on. - NBC News

Read More...

Assessing the Risk for Gout With SGLT2 Inhibitors in Patients With Diabetes – Annals of Internal Medicine

January 15th, 2020 1:41 am

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and Sinai Health System and University of Toronto, Toronto, Ontario, Canada (M.F.)

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (S.K.C., E.P., S.C.K.)

Financial Support: By the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Dr. Fralick received funding from the Eliot Phillipson Clinician-Scientist Training Program at the University of Toronto and the Canadian Institutes of Health Research through the Banting and Best PhD Award. Dr. Patorno is supported by a career development grant (K08AG055670) from the National Institute on Aging.

Disclosures: Dr. Patorno reports grants from the National Institute on Aging and Boehringer Ingelheim outside the submitted work. Dr. Kim reports grants from Pfizer, AbbVie, Roche, and Bristol-Myers Squibb outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at http://www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2610.

Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.

Reproducible Research Statement:Study protocol: Available from Dr. Fralick (e-mail, mike.fralick@mail.utoronto.ca). Statistical code: Not available. Data set: Available through IBM MarketScan (e-mail, watsonh@us.ibm.com).

Corresponding Author: Michael Fralick, MD, PhD, SM, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120; e-mail, mike.fralick@mail.utoronto.ca.

Current Author Addresses: Drs. Fralick, Chen, Patorno, and Kim: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120.

Author Contributions: Conception and design: M. Fralick, S.K. Chen, E. Patorno, S.C. Kim.

Analysis and interpretation of the data: M. Fralick, S.K. Chen, S.C. Kim.

Drafting of the article: M. Fralick, S.K. Chen.

Critical revision for important intellectual content: M. Fralick, S.K. Chen, E. Patorno, S.C. Kim.

Final approval of the article: M. Fralick, S.K. Chen, E. Patorno, S.C. Kim.

Statistical expertise: S.C. Kim.

Administrative, technical, or logistic support: M. Fralick, S.C. Kim.

Collection and assembly of data: M. Fralick.

Read more:
Assessing the Risk for Gout With SGLT2 Inhibitors in Patients With Diabetes - Annals of Internal Medicine

Read More...

Diabetes Distress and Depression – National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

January 15th, 2020 1:41 am

Learn about addressing the emotional side of living with diabetes as part of comprehensive diabetes care.

Jeffrey Gonzalez, PhD, is a co-author of the Psychiatric and Psychosocial Issues among Individuals Living with Diabetes chapter in the NIDDK publication Diabetes in America, 3rd Edition. Here, he discusses how depression and diabetes distress affect people living with diabetes and what health care professionals can do to help their patients.

Q: Why should health care professionals be concerned about depression in patients who have diabetes?

A: Health care professionals should be aware that depression is more common in people with diabetes, and, when its present, its associated with poor health outcomes in people who have diabetes.

A 2001 meta-analysis suggested that depression could be about twice as common in people with diabetes as in people without diabetes, and that's similar to what's been found in other chronic illnesses. In 2008, some colleagues and I did a meta-analysis of the literature that found depression was consistently associated with poor diabetes self-management. Other meta-analyses have found consistent associations between depression and hyperglycemia, increased risks of diabetes complications, and even early mortality.

Q: What is diabetes distress and how is it related to depression?

A: In the medical field and in many conversations around feeling down or blue, we often use the concept, clinical depression. Thats partly because the Diagnostic and Statistical Manual of Mental Health highlights depression as a mental health disorder that can be diagnosed based on certain symptoms. However, its hard to draw the line between clinical depression and emotional reactions to stressful situations. Big events, such as loss of a loved one or loss of employment, can cause emotional responses and symptoms that are very similar to those of depression, at least over the short term.

One way that depression and diabetes distress are different is that diabetes distress is not thought of as a mental illness. Diabetes distress is a construct proposed by researchers to describe the emotional response to living with diabetes, a life-threatening illness that requires chronic, demanding, self-management. However, tools used to screen for diabetes distress dont ask only about emotions. They also ask about problems people have with their diabetes, such as a lack of social support, a poor relationship with their doctor, or difficulty accessing health care. Diabetes distress captures a persons experience with the problems associated with diabetes.

Diabetes distress is much more common than clinical depression among patients with diabetes. Recent literature reviews suggest that between 30 and 40 percent of adults with diabetes are likely to report significant levels of diabetes distress over time.

Q: How is diabetes distress related to diabetes treatment adherence and self-management?

A: A body of research shows that people who report more diabetes distress are also more likely to report more problems with self-management and medication adherence and may also have higher blood glucose levels. Some evidence suggests they may also be more likely to experience hypoglycemia and fear of hypoglycemia, which can affect their ability and willingness to take their medications

Diabetes distress and everyday diabetes management are closely linked, and its probably a two-way street. People feel stressed and have emotional responses such as feeling down or hopeless. Then, they may avoid dealing with their diabetes and experience setbacks, such as hypoglycemia, hyperglycemia, or complications. Those setbacks further contribute to their distress, and it can become a vicious cycle.

Q: Among people with diabetes, do some people have a higher risk for depression or diabetes distress than others?

A: Yes, some people with diabetes appear to have a higher risk.

Q: How can health care professionals address depression or distress in patients who have diabetes?

A: Addressing the emotional side of living with diabetes should be part of comprehensive diabetes care. Emotional distress of some kind is going to be more common in patients living with diabetes and may be caused by some of the stresses related to diabetes.

Providers can ask questions about how people are doing, how theyre feeling, and what aspects of their diabetes are causing stress. Providers can also acknowledge and normalize the idea that diabetes distress is common and could occur sometime in the course of the illness, perhaps with the onset of complications or with life changes that make following a diabetes self-management routine more difficult.

Diabetes distress can cause people to feel stuck and to benefit less from their diabetes treatments. Providers should look out for people experiencing diabetes distress and offer support by talking with patients about distress and encouraging them to think about ways to better manage their distress. Providers may also be able to make the diabetes treatment regimen less burdensome for the patient.

Its also important for providers to identify mental health professionals who can collaborate as part of the care team and provide more specialized help when its needed. Providers should think about how to help their patients find someone who can assist with depression or more significant problems with diabetes distress.

Q: Is there anything else that health care professionals should know about depression and diabetes distress in people with diabetes?

A: Depression and diabetes distress can be treated. We know about treatments for depression, from psychotherapy to pharmacological treatments. Diabetes distress seems to respond to many different kinds of interventions, including educational and supportive interventions.

A number of questionnaires are available to help providers screen for depression and diabetes distress in patients. As with any screening tool, the majority of people who screen positive wont actually have the disorder. Providers need to talk with patients after the screening to further evaluate what's going on. At times, providers may feel they need input from a mental health specialist to make that differential diagnosis and to recommend the most appropriate treatment.

Providers can find more information about screening and monitoring patients for depression and diabetes distress in Psychosocial Care for People with Diabetes: A Position Statement of the American Diabetes Association.

Q: What research is being conducted on the relationship between depression and diabetes?

A: More research in this area is needed. One area of current research is the dissemination and implementation of treatment models that we already know can be helpful.

For example, Im currently finishing a National Institutes of Health-supported trial that focuses on providing self-management support by telephone to adults with type 2 diabetes who are not at goal with their A1C. This program has been evaluated in a few previous trials, and we incorporated new components to train and support health educators in offering interventions that may be helpful for depression and diabetes distress.

Many studies are addressing how effective treatments can reach a wider number of people who need them, for example through interventions delivered by peers or community health workers. We have a mental health crisis in this country, where our mental health system does not meet the need among patients who are already identified. Screening programs that identify more people who need care will require a workforce and better reimbursements to meet that need. Over the next few years, well see more research on translating expert recommendations into care for depression and diabetes distress that can be replicated in many settings and sustained over time.

How do you address depression and diabetes distress in your patients with diabetes? Tell us below in the comments.

Follow this link:
Diabetes Distress and Depression - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Read More...

‘Dining with Diabetes’ classes offered in Barryton – The Pioneer

January 15th, 2020 1:41 am

, Submitted to the Pioneer

'Dining with Diabetes' classes offered in Barryton

BARRYTON The Lions Club International and Michigan State University Extension are partnering to offer free "Dining with Diabetes" workshops in Barryton.

Thanks to the Lions Club International for giving back to this community. It is extra special to be able to bring 'Dining with Diabetes' to the small community of Barryton, MSUE educator Pam Daniels stated in a press release.

"Dining with Diabetes" lasts four weeks and includes research-based education, food preparation demonstrations and healthy recipe tasting. Participants receive a textbook and materials. The goals of the classes are for participants to learn self-management skills surrounding their health and to work closely with their healthcare providers.

"Dining with Diabetes" is for anyone with or at-risk of developing diabetes. Both diabetes self-care and cooking skills are taught each week. MSUE Chef Don Zimmer will be the featured guest chef each week.

Classes will take place from 1:30-3:30 p.m. Jan. 22 and 29, and Feb. 5 and 12, at the Barryton Senior Center, 71 E. Northern Ave.

RSVP is required. Call Lisa Baker at 231-592-0792 to sign up.

View original post here:
'Dining with Diabetes' classes offered in Barryton - The Pioneer

Read More...

What You Should Know About Eating Behaviors and Diabetes | SBM – Society of Behavioral Medicine

January 15th, 2020 1:41 am

Alyssa Vela, PhD; Health Psychology Fellow, McLaren FlintPhoutdavone Phimphasone-Brady, PhD; Postdoctoral Fellow, University of Colorado School of Medicine

If you have diabetes, you probably know all too well that eating is often the most challenging aspect of diabetes management. You are not alone if you struggle to figure out what to eat, when to eat, and how to eat, even years after a diabetes diagnosis. When it comes to eating and diabetes, there are a few key aspects to pay attention to. Some of these eating habits may be familiar to you, and they might even start to cause problems in your life, such as your blood sugar, your relationships with friends and family, or even your relationship with your doctor.

Be on the lookout for red flags that your eating habits may be problematic:

Everyone has to eat, so how we think about food and go about eating, plays a really important role in our happiness and well-being. There are many ways these patterns of eating can be improved to prevent any further eating-related problems and to help people meet their diabetes management goals. Such strategies include:

If your eating habits affect your life and ability to manage diabetes, talk to your doctor, a diabetes educator, and/or a mental health provider who specializes in helping patients with the challenges associated with diabetes management (a list can be found here).

Back to Healthy Living

More:
What You Should Know About Eating Behaviors and Diabetes | SBM - Society of Behavioral Medicine

Read More...

25 years, $31 million: How Houston running community has helped area charities – Houston Chronicle

January 15th, 2020 1:41 am

Every time Jennifer Hunt crosses a finish line, her mother, her brother and her niece flash in her mind.

She runs for those three, she said, and all those diagnosed with Type 1 diabetes at an early age. Her mother died from diabetes-related complications when Hunt was 33.

Also known as juvenile diabetes, people can live for years with the disease but it is not an easy life. Hunts mother was diagnosed with Type 1 diabetes when she was 14; her brother at age 9; and her niece at age 6.

I lost my best friend and my rock. My brother is 55 and is in end-stage renal failure. My niece is my champion and is such an awesome young lady, said Hunt, 51. I run in remembrance of my mom, and I champion my niece as my reason to give her strength knowing someone understands her and what she is going through.

Through the Chevron Houston Marathon Run for a Reason Program, the Sugar Land resident is raising funds for the Juvenile Diabetes Research Fund. Last year, she raised about $5,000. This year, she is attempting to raise at least $2,500.

Since 1995, the marathon has hosted the charity program as way for race organizers to connect local philanthropies with the running community, raising more than $31 million since its inception.

On HoustonChronicle.com: Muffy King's journey started in the water. Now she creates Houston running events.

Two years ago, Hunt started running after she was diagnosed with leukemia at age 50. She needed an outlet to deal with the road ahead that was filled with doctors appointments and cancer treatment.

Hunts mother, Lucille B. Isdale, was an active volunteer for the JDRF, a nonprofit organization at the forefront of diabetes research. The foundation funds medical trials and studies that led to the first lab-engineered insulin decades ago. More recently, the foundation helped pay for studies related to an artificial pancreas device system, necessary for diabetics to regulate glucose.

This year, Hunt will auction a custom guitar by heavy metal guitarist Dan Fastuca, podium hats from Mazda race car driver Luke Oxner and a gift certificate to Sugar Land MMA. So far, she has raised $1,810.

I turned the worst time of my life into the most rewarding time by doing for others, Hunt said. I want to carry on my moms legacy and the work she did with JDRF. Every finish line I cross is such a victory on so many levels: fighting cancer and fighting for a cure for children (with diabetes) and families like mine.

Sundays half marathon will be Hunts fifth 13.1-mile race. She was aiming to race a full marathon this time, but two surgeries in July put her behind in training. She plans to train for the full marathon next year.

While working full-time, training and raising money for the foundation, Hunt is still fighting leukemia. Her next treatment will be two days after her race; she received her physicians permission to run.

You either become a victim or a victor, she said. I hope the example I set for my niece is no matter what is going on in life, go for being the victor.

This years Run for a Reason program kicked off Dec. 3 with a social media contest. As sponsor partner, Chevron donates $75,000, to be split between three charities: the charity that raises the most money; the one with the most votes; and the charity that receives the most donations from individual donors.

On HoustonChronicle.com: New mom's Houston Marathon goal isn't about pace -- it's leaving a legacy for her daughter

The winners will be announced Friday.

Every charity part of our program has local ties to Houston, said Muffy King, the marathons director of marketing, media and branding. The money is staying here, which resonates with our community.

Charity runners have to raise at least $350 to $500 to qualify for the race, but many raise thousands.

Kung Fu Running Club, already a mainstay with weekly recreational runs at Kung Fu Saloon, has coordinated Happy Hours to raise funds for its chosen charity. Many use social media, GoFundMe accounts and email campaigns, as well.

Its a cliche, but it takes a community for efforts like this. Whats great about our community is everyone is willing to help, King said.

There are 65 charities, 150 running teams and 1,160 fundraisers in this years program.

Currently, the top fundraiser so far is Lawrence Despain who has raised nearly $19,000 for the Snowdrop Foundation, Inc., an organization that provides college scholarships for pediatric cancer patients and childhood cancer survivors.

julie.garcia@chron.com

Twitter: @reporterjulie

View post:
25 years, $31 million: How Houston running community has helped area charities - Houston Chronicle

Read More...

Something Chronic: How a Gut Infection May Lead to IBS – Technology Networks

January 13th, 2020 3:51 pm

Sometimes the end of an intestinal infection is just the beginning of more misery. Of those who contract travelers diarrhea, for example, an unlucky few go on to develop irritable bowel syndrome (IBS), a chronic inflammation of the intestinal tract.

Scientists arent sure exactly how this happens, but some think an infection may contribute to IBS by damaging the gut nervous system. A new Rockefeller study takes a close look at why neurons in the gut die and how the immune system normally protects them.

Conducted with mice, the experiments offer insight on IBS and could point toward potential new treatment approaches.

Keeping inflammation in check

In a healthy gut, the immune system must strike a careful balance between responding to threats and keeping that response in check to avoid damage.

Inflammation helps the gut ward off an infection, but too much of it can cause lasting harm, says Daniel Mucida, an associate professor and head of the Laboratory of Mucosal Immunology. Our work explores the complex mechanisms that prevent inflammatory responses from destroying neurons.

To understand the effects of an infection on the nervous system, Mucida and his colleagues gave mice a weakened form of Salmonella, a bacterium that causes food poisoning, and analyzed neurons within the intestine. They found that infection-induced a long-lasting reduction of neurons, an effect they attributed to the fact these cells express two genes, Nlrp6 and Caspase 11, which can contribute to a specific type of inflammatory response.

This response, in turn, can ultimately prompt the cells to undergo a form of programmed cell death. When the researchers manipulated mice to eliminate these genes specifically in neurons, they saw a decrease in the number of neurons expiring.

This mechanism of cell death has been documented in other types of cells, but never before in neurons, says Fanny Matheis, a graduate student in the lab. We believe these gut neurons may be the only ones to die this way.

Macrophages to the rescue

Its not yet clear exactly how inflammation causes neurons to commit cell suicide, yet the scientists already have clues suggesting it might be possible to interfere with the process. The key may be a specialized set of gut immune cells, known as muscularis macrophages.

Previous work in Mucidas lab has shown that these cells express inflammation-fighting genes and collaborate with the neurons to keep food moving through the digestive tract. If these neurons die off, as happens in an infection, a possible result is constipationone of a number of unpleasant IBS symptoms. In their recent report, the team demonstrate how macrophages come to the neurons aid during an infection, ameliorating this aspect of the disorder.

Their experiments revealed that macrophages possess a certain type of receptor molecule that receives stress signals released by another set of neurons in response to an infection. Once activated, this receptor prompts the macrophage to produce molecules called polyamines, which the scientists think might interfere with the cell death process.

Getting back to normal

In other experiments, the researchers found that Salmonella infection alters the community of microbes within the guts of miceand when they restored the animals intestinal flora back to normal, the neurons recovered.

Using what we learned about the macrophages, one could think about ways to disrupt the inflammatory process that kills the neurons, says Paul Muller, a postdoctoral fellow in the lab.

For instance, it might be possible to develop better treatments for IBS that work by boosting polyamine production, perhaps through diet, or by restoring gut microbial communities. Since short-term stress responses also appear to have a protective effect, Muller thinks it may also be helpful to target that system.

Reference

Matheis et al. (2020) Adrenergic Signaling in Muscularis Macrophages Limits Infection-Induced Neuronal Loss. Cell. DOI: https://doi.org/10.1016/j.cell.2019.12.002

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Here is the original post:
Something Chronic: How a Gut Infection May Lead to IBS - Technology Networks

Read More...

The Secrets to a Healthier, Happier You in 2020 Podcast Episode 3 Reveals Secrets to Maintaining a Healthy Immune System – Us Weekly

January 13th, 2020 3:51 pm

Staying healthy in 2020! The No. 1 factor in remaining healthy and not getting sick is a strong immune system!

On episode 3 of The Secrets to a Healthier, Happier You in 2020 podcast, Us Weeklys Christina Garibaldi is joined by RxSavers medical expert Dr. Holly Phillips to discuss everything you need to know about maintaining a healthy immune system.

Its essentially our bodies defense against everything outside, and particularly diseases and infections, Phillips explains. Ranging from viruses and bacteria and everything thats outside of our body that we want to keep out.

The first tip? Get enough sleep.

I really have to emphasize that, the doc reveals. If you dont get enough sleep, it creates a cascade of stress hormones.

During the episode, Phillips also reveals the right and wrong foods to help your immune system stay strong.

If youd like to boost your immune system, make your plate as colorful as possible, she says. Brightly colored fruits and vegetables If its really bright, you know you have the antioxidants you need.

For more tips to avoid catching the common cold or ending up stuck on the couch for weeks, listen to Secrets to a Healthier, Happier You episode 3.

The podcast, which also tackles mental health, New Years resolutions and more, is available on Apple Podcasts, Spotify, Google Podcasts and Stitcher.

Read the original here:
The Secrets to a Healthier, Happier You in 2020 Podcast Episode 3 Reveals Secrets to Maintaining a Healthy Immune System - Us Weekly

Read More...

White blood cells: Function, ranges, types, and more – Medical News Today

January 13th, 2020 3:51 pm

White blood cells circulate around the blood and help the immune system fight off infections.

Stem cells in the bone marrow are responsible for producing white blood cells. The bone marrow then stores an estimated 8090% of white blood cells.

When an infection or inflammatory condition occurs, the body releases white blood cells to help fight the infection.

In this article, learn more about white blood cells, including the types and their functions.

Health professionals have identified three main categories of white blood cell: granulocytes, lymphocytes, and monocytes. The sections below discuss these in more detail.

Granulocytes are white blood cells that have small granules containing proteins. There are three types of granulocyte cells:

These white blood cells include the following:

Monocytes are white blood cells that make up around 28% of the total white blood cell count in the body. These are present when the body fights off chronic infections.

They target and destroy cells that cause infections.

According to an article in American Family Physician, the normal range (per cubic millimeter) of white blood cells based on age are:

The normal range for a pregnant women in the 3rd trimester is 5,80013,200 per cubic millimeter.

If a person's body is producing more white blood cells than it should be, doctors call this leukocytosis.

A high white blood cell count may indicate the following medical conditions:

Surgical procedures that cause cells to die can also cause a high white blood cell count.

If a person's body is producing fewer white blood cells than it should be, doctors call this leukopenia.

Conditions that can cause leukopenia include:

Doctors may continually monitor white blood cells to determine if the body is mounting an immune response to an infection.

During a physical examination, a doctor may perform a white blood cell count (WBC) using a blood test. They may order a WBC to test for, or rule out, other conditions that may affect white blood cells.

Although a blood sample is the most common approach to testing for white blood cells, a doctor can also test other body fluids, such as cerebrospinal fluid, for the presence of white blood cells.

A doctor may order a WBC to:

The following are conditions that may impact how many white blood cells a person has in their body.

This is a condition wherein a person's body destroys stem cells in the bone marrow.

Stem cells are responsible for creating new white blood cells, red blood cells, and platelets.

This is an autoimmune condition wherein the body's immune system destroys healthy cells, including red and white blood cells.

HIV can decrease the amount of white blood cells called CD4 T cells. When a person's T cell count drops below 200, a doctor might diagnose AIDS.

Leukemia is a type of cancer that affects the blood and bone marrow. Leukemia occurs when white blood cells rapidly produce and are not able to fight infections.

This condition causes a person's body to overproduce some types of blood cells. It causes scarring in a person's bone marrow.

Whether or not a person needs to alter their white blood cell count will depend on the diagnosis.

If they have a medical condition that affects the number of white blood cells in their body, they should talk to a doctor about the goals for their white blood cell count, depending on their current treatment plan.

A person can lower their white blood cell count by taking medications such as hydroxyurea or undergoing leukapheresis, which is a procedure that uses a machine to filter the blood.

If a person's white blood cell count is low due to cancer treatments such as chemotherapy, a doctor may recommend avoiding foods that contain bacteria. This may help prevent infections.

A person can also take colony-stimulating factors. These may help prevent infection and increase the number of white blood cells in the body.

White blood cells are an important part of the body's immune system response. There are different types of white blood cell, and each has a specific function in the body.

Certain conditions can affect the number of white blood cells in the body, causing them to be too high or too low.

If necessary, a person can take medication to alter their white blood cell count.

More here:
White blood cells: Function, ranges, types, and more - Medical News Today

Read More...

Are consumers concerned about their immunity? – New Food

January 13th, 2020 3:51 pm

Based on FMCG Gurus The Impact of Immunity Global Report 2020, Will Cowling explores how the results reflect a consumer shift towards a focus on immunity when considering diet.

Immunity is becoming a key area in which consumers are looking to actively improve. This is due to many factors including changing dietary habits and greater levels of inactivity, which is having an impact on consumer health. Many people can be concerned about germs and bacteria and are also becoming more educated on the topic of immunity. This is leading to consumers being more proactive when it comes to addressing the immune system. So, what are consumers doing to improve their immune system?

FMCG Gurus research shows that 54 percent of global consumers believe to have a good or very good immune system. However, 25 percent still believe they do not have a good immune system. The growing rise of consumers understanding the importance of immunity aligns with consumers embracing the concepts of holistic health and being healthier for longer. People are recognising the link between their immune system and their overall health. This being said, three in 10 consumers state they have suffered from health problems which has impacted the quality of their day-to-day life.

The growing rise of consumers understanding the importance of immunity aligns with consumers embracing the concepts of holistic health and being healthier for longer

Consumers associate many different variables to what constitutes a poor immune system. Globally, the majority of people believe that being easily susceptible to day-to-day illness such as catching a cold (61 percent) is a key sign to a poor immune system. FMCG Gurus consumer insights show that four in 10 consumers feel vulnerable to illness. This is a further reflection of how a considerable proportion of consumers across the globe are not satisfied with their immune system.

Half of consumers in the last 12 months have looked to improve their immune systems. Consumers are taking a proactive approach to health maintenance and recognise that a good immune system is not linked to physical health alone. Mental wellness is also at the forefront of consumers minds as 54 percent stated that they have looked to improve their mental wellness to improve their overall quality of life and immune system.

Consumers are taking a proactive approach to health maintenance and recognise that a good immune system is not linked to physical health alone

One key movement that consumers are trying to improve their immune system through is by eating more fresh vegetables (63 percent). Globally, consumers are changing their diets, another key change which have consumers have made is increase their protein intake (62 percent). This shows that consumers are taking an active approach to their health. This is also seen as 35 percent of consumers stated that they do not suffer with any problems but wanted to take a proactive approach to their health.

Food and beverage products are one of the main ways in which consumers look to improve their health. Globally, 58 percent of consumers would be interested in products that promote heart health, cognitive health and immune health benefits. This is the same with nutritional supplements; although the research shows consumers may not necessarily be seeking such products out, it does show that they want products with active ingredients. FMCG Gurus research shows that iron is the ingredient consumers most associate with boosting their immune systems (70 percent).

Consumers are now prioritising their health and are actively looking to keep their immune system in top condition to stay fitter and healthier for longer. The rise in people taking a proactive approach has led to many opportunities within food and drink. As such, the industry should encourage consumers to take steps to improve their health and wellness in general, because this will have a positive impact on their immunity.

As Marketing Manager of FMCG Gurus, Will Cowling is responsible for managing day to day marketing tasks ranging from campaigns to PR, to managing content on social channels and the website. Understanding the business and the industry is key to providing innovative ideas and producing quality content. He has a strong focus on evaluating consumer perceptions and deciphering insights.

See the rest here:
Are consumers concerned about their immunity? - New Food

Read More...

New Podcast Reveals Tips to Boost Your Immune System – In Touch Weekly

January 13th, 2020 3:51 pm

All available episodes can be streamed on all major podcast platforms: LISTEN NOW

Staying healthy in 2020! The No. 1 factor in remaining healthy and not getting sick is a strong immune system!

On episode 3 of The Secrets to a Healthier, Happier You in 2020 podcast, Us Weeklys Christina Garibaldi is joined by RxSavers medical expert Dr. Holly Phillips to discuss everything you need to know about maintaining a healthy immune system.

Its essentially our bodies defense against everything outside, and particularly diseases and infections, Phillips explains. Ranging from viruses and bacteria and everything thats outside of our body that we want to keep out.

The first tip? Get enough sleep.

I really have to emphasize that, the doc reveals. If you dont get enough sleep, it creates a cascade of stress hormones.

During the episode, Phillips also reveals the right and wrong foods to help your immune system stay strong.

If youd like to boost your immune system, make your plate as colorful as possible, she says. Brightly colored fruits and vegetables If its really bright, you know you have the antioxidants you need.

For more tips to avoid catching the common cold or ending up stuck on the couch for weeks, listen to Secrets to a Healthier, Happier You episode 3.

The podcast, which also tackles mental health, New Years resolutions and more, is available on Apple Podcasts, Spotify, Google Podcasts and Stitcher.

Continued here:
New Podcast Reveals Tips to Boost Your Immune System - In Touch Weekly

Read More...

Page 727«..1020..726727728729..740750..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick